Cargando…

Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae

Antibiotic-resistant infections caused by gram-negative bacteria are a major healthcare concern. Repurposing drugs circumvents the time and money limitations associated with developing new antimicrobial agents needed to combat these antibiotic-resistant infections. Here we identified the off-patent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carlson-Banning, Kimberly M., Chou, Andrew, Liu, Zhen, Hamill, Richard J., Song, Yongcheng, Zechiedrich, Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720592/ https://www.ncbi.nlm.nih.gov/pubmed/23936064 http://dx.doi.org/10.1371/journal.pone.0069646

Ejemplares similares

Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli
por: Conley, Zachary C., et al.
Publicado: (2019)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii
por: Alarfaj, Reem E., et al.
Publicado: (2022)

Mortality difference from Klebsiella aerogenes vs Enterobacter cloacae bloodstream infections
por: Chou, Andrew, et al.
Publicado: (2023)

Catabolite and Oxygen Regulation of Enterohemorrhagic Escherichia coli Virulence
por: Carlson-Banning, Kimberly M., et al.
Publicado: (2016)

Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent
por: Feng, Hongxuan, et al.
Publicado: (2020)

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
por: Lu, Peggy, et al.
Publicado: (2023)

Acinetobacter baumannii Antibiotic Resistance Mechanisms
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
por: Gontijo, Aline Vidal Lacerda, et al.
Publicado: (2021)

Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008–2013
por: Agodi, Antonella, et al.
Publicado: (2015)

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints
por: Kuti, Joseph L, et al.
Publicado: (2018)

Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria
por: Cho, Hyejin, et al.
Publicado: (2022)

Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii
por: Russo, Thomas A., et al.
Publicado: (2022)

Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance
por: Abdi, Seyyed Naser, et al.
Publicado: (2020)

Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People’s Democratic Republic
por: Cusack, Tomas-Paul, et al.
Publicado: (2019)

Antibiotic Consumption in Hospitals and Resistance Rate of Klebsiella pneumoniae and Escherichia coli in Montenegro
por: Mijović, Gordana, et al.
Publicado: (2020)

Frequency of Beta-Lactamase Antibiotic Resistance Genes in Escherichia Coli and Klebsiella pneumoniae
por: Golsha, Roghieh, et al.
Publicado: (2021)

Dual infection with Acinetobacter baumannii and Klebsiella pneumoniae in a patient with multiple comorbidities – case presentation
por: Săndulescu, Oana, et al.
Publicado: (2014)

Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence
por: Semenec, Lucie, et al.
Publicado: (2023)

Evaluation of DNA Extraction Methods for Reliable Quantification of Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa
por: Bogožalec Košir, Alexandra, et al.
Publicado: (2023)

Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
por: Cheng, Yu-Shan, et al.
Publicado: (2019)

Nosocomial Acinetobacter baumannii Infections and Changing Antibiotic Resistance
por: Necati Hakyemez, Ismail, et al.
Publicado: (2013)

Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
por: Geisinger, Edward, et al.
Publicado: (2015)

The Impact of Antibiotic Consumption on Development of Acinetobacter Baumannii Resistance
por: Granov, Djana, et al.
Publicado: (2016)

Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumannii
por: Kröger, Carsten, et al.
Publicado: (2016)

Hydrogen Sulfide Sensitizes Acinetobacter baumannii to Killing by Antibiotics
por: Ng, Say Yong, et al.
Publicado: (2020)

Integron Associated Antibiotic Resistance among Acinetobacter baumannii
por: Ranjbar, Reza, et al.
Publicado: (2021)

Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location
por: Boyd, Lauren Becnel, et al.
Publicado: (2008)

Silver Nanostar-Based SERS for the Discrimination of Clinically Relevant Acinetobacter baumannii and Klebsiella pneumoniae Species and Clones
por: de Almeida, Miguel Peixoto, et al.
Publicado: (2023)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

Assessment of physiological and electrochemical effects of a repurposed zinc dithiocarbamate complex on Acinetobacter baumannii biofilms
por: Yang, Qing, et al.
Publicado: (2022)

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli
por: Gaurav, Amit, et al.
Publicado: (2021)

Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine
por: Gu, Hao, et al.
Publicado: (2018)

Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates
por: Shenkutie, Abebe Mekuria, et al.
Publicado: (2020)

Antibiotic Resistance and Genotypes of Nosocomial Strains of Acinetobacter baumannii in Kazakhstan
por: Lavrinenko, Alyona, et al.
Publicado: (2021)

Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection
por: Roy, Subhasree, et al.
Publicado: (2022)

Stapling of Peptides Potentiates the Antibiotic Treatment of Acinetobacter baumannii In Vivo
por: Schouten, Gina K., et al.
Publicado: (2022)

Antibiotics, Acid and Heat Tolerance of Honey adapted Escherichia coli, Salmonella Typhi and Klebsiella pneumoniae
por: Ayub, Rabia, et al.
Publicado: (2020)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_affnjrfgm7671d9u6vm38vt04l